SUBSCRIBERS

Chugai investing S$476m more into S'pore facility

Funds will be used to boost Japanese drug maker's local employee base and antibody R&D pipeline

Published Wed, Jan 28, 2015 · 09:50 PM

Singapore

JAPANESE drug maker Chugai Pharmaceutical on Wednesday announced that it will invest S$476 million from now until 2021 into its research institute in Singapore, Chugai Pharmabody Research (CPR).

When CPR first set up its corporate laboratory here in 2012 to develop antibody drugs, it planned to pour about S$200 million into antibody research over the subsequent five years.

The new grant now comes on top on that. In a statement on Wednesday, it said: "CPR has progressed as initially expected, and this addition…

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes